Novel conjunctival incision apple muscle reduction method

By employing a novel conjunctival incision method for cheek reduction, combined with minimally invasive puncture and specific suture needles, stable reduction of the cheekbone was achieved, resolving mid-facial aging issues. The procedure is short, yields stable results, and has no significant complications.

CN121370264APending Publication Date: 2026-01-23何柏慧
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202511959866.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-12-24
Publication Date
2026-01-23

AI Technical Summary

Technical Problem

Existing cheekbone repositioning techniques suffer from problems such as significant trauma, long recovery period, short-lived effects, and unstable fixation, and cannot effectively address mid-facial aging manifestations such as eye bags, tear troughs, and Indian lines.

Method used

A novel method for repositioning the cheekbone through a conjunctival incision was adopted. This method combines minimally invasive puncture, orbital septum tightening and fixation, SOOF lifting and anchoring, and fat pad mesh ligation with 5-0 non-absorbable polyethylene terephthalate sutures and 21G blunt needles to achieve both minimal invasiveness and strong fixation.

Benefits of technology

It achieves an anatomical solution to mid-facial aging problems, with a short operation time, stable results, and immediate postoperative repositioning effect. There is no significant swelling or complications, and no risk of fat displacement within 12 months.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN121370264A_ABST
    Figure CN121370264A_ABST
Patent Text Reader

Abstract

The invention provides a novel conjunctival incision apple muscle reduction method. The novel conjunctival incision apple muscle reduction method comprises the following steps: S1, preoperative positioning; s2, minimally invasive puncture; s3, orbital septum tightening and fixing; s4, carrying out SOOF lifting and anchoring; s5, netted bundling of the fat pad; s6, wound treatment. According to the structure provided by the embodiment of the invention, a triple-effect collaborative reduction mechanism of orbital septum tightening, SOOF lifting and fat pad bundling is provided, and the core problem of facial aging is solved from the anatomical level; the adaptive parameters of the wire rod and the needle head are optimized, the combination scheme of the 5-0 PET wire and the 21G blunt-end needle head is defined, and the minimally invasive property and the fixing strength are both considered; a standardized operation process is established, and operation repeatability and effect stability are ensured through specific data such as puncture point spacing, suture needle pitch, tension control and the like.
Need to check novelty before this filing date? Find Prior Art

Description

TECHNICAL FIELD

[0001] The application relates to the technical field of conjunctival incision malar muscle reduction methods, in particular to a novel conjunctival incision malar muscle reduction method. BACKGROUND

[0002] With age, problems such as orbital fat herniation, SOOF descent, and zygomatic fat pad relaxation and sagging can cause signs of midfacial aging such as eye bags, tear troughs, and Indian lines. Existing malar muscle reduction techniques mainly include external incision eye bag correction combined with malar muscle lifting, injection filling, and thread sculpture lifting, but have many defects: external incision surgery has large trauma, high risk of postoperative scarring, wide dissection range that easily damages blood vessels and nerves, and a long operation time of 60-90 minutes and a long recovery period; injection filling has a short effect and needs repeated injection, and can cause complications such as fat embolism and nodule formation; traditional thread sculpture lifting has unstable fixed points, is prone to thread slippage, can only improve surface relaxation, and cannot solve the problem of fat herniation and depression coexisting, and therefore a novel conjunctival incision malar muscle reduction method is proposed. SUMMARY

[0003] The application provides a novel conjunctival incision malar muscle reduction method to solve the above-mentioned problems.

[0004] The application provides a novel conjunctival incision malar muscle reduction method, which comprises the following method: S1, preoperative positioning; The preoperative positioning comprises marking two puncture points on the inner side and the outer side of the lower conjunctival fornix, determining the orbital fat herniation area, the SOOF lifting target point, and the zygomatic fat pad descent range; S2, minimally invasive puncture; The minimally invasive puncture uses a 21G blunt needle to puncture into the subconjunctival space from the two puncture points, and separates along the superficial layer of the orbital septum to the preset operation area, with a separation range controlled within 1.5-2.0 cm2 to avoid damaging the palpebral arterial arch and the infraorbital nerve; S3, orbital septum tightening and fixation; The orbital septum tightening and fixation uses 5-0 non-absorbable polyethylene terephthalate sutures to perform 3-4 needle continuous sutures between the attachment point of the lateral wall of the orbital septum and the central part of the orbital septum by the needle embedding suture technique, so that the orbital septum and the orbital fat are collectively moved downward by 3-5 mm and tightened, and the suture tension is controlled within 0.3-0.5 N; S4, SOOF lifting and anchoring; The SOOF lifting and anchoring passes the free end of the suture through the SOOF layer in the first third area of the zygomatic arch, performs 1-2 needle horizontal mattress sutures, lifts the SOOF layer to move upward by 4-6 mm, and the knot tying strength is taken as the standard that the SOOF layer does not slip, and the knot is buried in the tissue after being tied; S5, fat pad reticulated ligation; The fat pad reticulated ligation is performed by using another suture to reticulate cross suture through the same puncture channel, and the fat pad of the eye bag and the fat pad of the lower cheek are fixed by ligation, and the suture grid aperture is 0.8-1.2 cm, so that the fat pad is ensured not to be displaced. S6, wound treatment; The wound treatment includes removing the excess suture after confirming the reduction effect, the puncture point does not need to be sutured, and the wound is pressed and bandaged for 5-10 minutes after applying an antibacterial ointment.

[0005] Preferably, the breaking strength of the 5-0 non-absorbable polyethylene terephthalate suture is ≥5.0 N, the wire diameter is 0.15-0.18 mm, the surface is treated by polytetrafluoroethylene coating, and the friction coefficient is ≤0.12.

[0006] Preferably, the distance between the puncture points in the minimally invasive puncture is 2.5-3.5 cm, the puncture depth is controlled to be 2.0-3.0 mm, physiological saline is continuously flushed and cooled during the separation process, and the temperature is maintained at 32-35℃.

[0007] Preferably, in the needle embedding suture technique, the needle distance of the orbital septum suture is 4-6 mm, the angle between the suture and the orbital septum tissue is 30-45°, and the orbital septum tension is uniformly distributed after suture, without local wrinkles.

[0008] Preferably, the SOOF lifting anchor position is 2.0-2.5 cm away from the infraorbital margin, and the suture depth is 1.5-2.0 mm, avoiding penetrating the zygomatic periosteum.

[0009] Preferably, the suture intersection angle of the reticulated ligation is 60-90°, the number of suture winding turns of each fat pad fixing point is 2-3 turns, and the knotting mode adopts a surgical square knot, so as to ensure the fixing stability and no risk of fat displacement within 12 months after the operation.

[0010] The above technical solutions provided by the embodiments of the present application have the following advantages compared with the prior art: The structure provided by the embodiments of the present application proposes a three-effect synergistic reduction mechanism of orbital septum tightening, SOOF lifting and fat pad ligation, solves the core problem of midfacial aging from the anatomical level, optimizes the adaptation parameters of the wire and the needle, clearly defines the combination scheme of the 5-0 PET wire and the 21G blunt needle, and considers the minimally invasive and fixing strength, establishes a standardized surgical procedure, and through specific data such as puncture point distance, suture needle distance and tension control, ensures the repeatability and stability of the operation effect. BRIEF DESCRIPTION OF DRAWINGS

[0011] The accompanying drawings, which are incorporated into and form part of the specification, illustrate embodiments consistent with the present application and, together with the specification, serve to explain the principles of the application.

[0012] In order to more clearly illustrate the technical solutions of the embodiments of the present application or the prior art, the accompanying drawings needed to be used in the embodiments or prior art description will be briefly introduced as follows. Obviously, for those of ordinary skill in the art, other drawings can also be obtained based on these drawings without any creative effort.

[0013] Figure 1 The overall method flowchart of the present application. DETAILED DESCRIPTION

[0014] In order to make the objects, technical solutions and advantages of the embodiments of the present application clearer, the technical solutions in the embodiments of the present application will be described clearly and completely in combination with the accompanying drawings in the embodiments of the present application. Obviously, the described embodiments are only a part of the embodiments of the present application, rather than all the embodiments of the present application. Based on the embodiments in the present application, all other embodiments obtained by those of ordinary skill in the art without any creative effort fall within the scope of protection of the present application.

[0015] Various embodiments of the present application can exist in the form of a range. It should be understood that the description in the form of a range is merely for the convenience and brevity, and should not be understood as a hard restriction on the scope of the present application. Therefore, it should be considered that the described range has been specifically disclosed all possible sub-ranges and single values in the range. For example, it should be considered that the range description from 1 to 6 has specifically disclosed sub-ranges, such as from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2 to 6, from 3 to 6, etc., as well as single numbers in the described range, such as 1, 2, 3, 4, 5 and 6, which applies to any range. In addition, whenever a numerical range is indicated in the present application, it refers to any cited number (fraction or integer) in the indicated range. Unless otherwise specified, various raw materials, reagents, instruments and equipment used in the present application can be purchased from the market or can be prepared by existing equipment.

[0016] In the present application, the orientation words such as "upper" and "lower" are specifically the directions of the drawing surface in the drawings unless otherwise stated. In addition, in the present application, the terms "include", "contain" and the like mean "include but not limited to". In the present application, the relational terms such as "first" and "second" are only used to distinguish one entity or operation from another entity or operation, and do not necessarily require or imply any such actual relationship or order between the entities or operations. In the present application, "and / or" describes the association relationship of the associated objects, which means that there can be three kinds of relationships, for example, A and / or B can represent the cases of A alone, A and B together, and B alone. Wherein A and B can be singular or plural. In the present application, "at least one" means one or more, and "multiple" means two or more. "At least one", "at least one of the following" or the like means any combination of the items, including any combination of single or multiple items. For example, "at least one of a, b, or c", or "at least one of a, b, and c", can represent a, b, c, a-b (a and b), a-c, b-c, or a-b-c, where a, b, and c can be single or multiple.

[0017] As shown in Figure 1 The present application provides a new type of conjunctival incision apple muscle reduction method, which comprises the following methods: S1, preoperative positioning; The preoperative positioning includes marking two puncture points on the inner and outer sides of the lower eyelid conjunctival fornix, determining the orbital septum fat bulging area, SOOF lifting target point and lower migration range of the zygomatic fat pad; S2, minimally invasive puncture; The minimally invasive puncture uses a 21G blunt needle, which is inserted into the subconjunctival space from the two puncture points, and separated along the superficial layer of the orbital septum to the preset operation area. The separation range is controlled within 1.5-2.0 cm² to avoid damaging the palpebral arterial arch and infraorbital nerve; S3, orbital septum tightening and fixation; The orbital septum tightening and fixation uses 5-0 non-absorbable polyethylene terephthalate suture, which is used for 3-4 needle continuous suture between the attachment point of the lateral wall of the orbital septum and the central part of the orbital septum by needle embedding suture technique, so that the orbital septum and the orbital septum fat are moved downward by 3-5 mm and tightened. The suture tension is controlled within 0.3-0.5 N; S4, SOOF lifting and anchoring; The SOOF lifting and anchoring passes the free end of the suture through the SOOF layer in the first third area of the zygomatic arch, and performs horizontal mattress suture of 1-2 needles to lift the SOOF layer by 4-6 mm. The knot tying force of the suture is based on the standard of no sliding of the SOOF layer, and the knot is buried in the tissue after tying; S5, fat pad reticulated ligation; The fat pad reticulated ligation is performed by reticulated cross-stitching with another suture through the same puncture channel to fix the fat pads of the eye bags and the fat pads of the lower cheek, the stitching grid aperture is 0.8-1.2 cm, and the fat pads are ensured not to be displaced. S6, wound treatment; The wound treatment includes removing the excess sutures after confirming the reduction effect, the puncture points do not need to be sutured, and the wound is pressed and bandaged for 5-10 minutes after applying an antibacterial ointment.

[0018] The breaking strength of the 5-0 non-absorbable polyethylene terephthalate suture is ≥5.0 N, the wire diameter is 0.15-0.18 mm, the surface is treated with a polytetrafluoroethylene coating, and the friction coefficient is ≤0.12.

[0019] The puncture point spacing in the minimally invasive puncture is 2.5-3.5 cm, the puncture depth is controlled at 2.0-3.0 mm, physiological saline is continuously flushed and cooled during the separation process, and the temperature is maintained at 32-35°C.

[0020] In the needle embedding suture technique, the needle spacing for the orbital septum suture is 4-6 mm, the angle between the suture and the orbital septum tissue is 30-45°, and the orbital septum tension is uniformly distributed after suture, without local wrinkles.

[0021] The SOOF lifting anchor position is 2.0-2.5 cm away from the infraorbital margin, and the suture depth is 1.5-2.0 mm to avoid penetrating the zygomatic periosteum.

[0022] The suture intersection angle of the reticulated ligation is 60-90°, the number of suture winding turns at each fat pad fixation point is 2-3 turns, and the knot tying method is a surgical square knot to ensure the stability of the fixation, and there is no risk of fat displacement within 12 months after the operation.

[0023] Principle: Example 1 1. Preoperative preparation: the patient is placed in a supine position, the eye is disinfected, and a sterile drape is placed, 0.5% lidocaine + 0.1% epinephrine mixed solution (ratio 1:100000) is used for subconjunctival local infiltration anesthesia, and the injection amount of each side is ≤1.5 ml.

[0024] 2. Puncture point positioning: mark two puncture points on the medial side (5 mm from the medial canthus) and the lateral side (8 mm from the lateral canthus) of the inferior conjunctival fornix with a marker pen, with a spacing of 3.0 cm.

[0025] 3. Puncture and separation: a 21G blunt needle (length 38 mm) is inserted from the medial puncture point, and the orbital septum is separated outward along the superficial layer, with a separation range of 1.8 cm² and a depth of 2.5 mm, physiological saline is used for flushing and cooling during the process to avoid tissue damage; the same method is used to complete the separation of the lateral puncture point.

[0026] 4. Tightening of the orbital septum: 5-0 PET non-absorbable thread is inserted from the lateral wall of the orbital septum, and 4 continuous stitches are made to the central part of the orbital septum, with a needle distance of 5 mm and a thread angle of 35° with the orbital septum. The orbital septum is lowered by 4 mm by pulling the thread, and the tension is controlled at 0.4 N. The knot is fixed.

[0027] 5. SOOF lifting: The free end of the suture is passed to the SOOF layer in the anterior 1 / 3 region of the malar arch (2.2 cm from the lower orbital margin), and 1 horizontal mattress suture is made with a depth of 1.8 mm. The SOOF layer is lifted by 5 mm, and the surgical square knot is fixed and buried in the tissue.

[0028] 6. Fat pad ligation: The suture is inserted through the lateral puncture point, and the fat pad of the eye bag and the malar fat pad is sutured in a mesh pattern with a crossing angle of 75° and a grid aperture of 1.0 cm. Each fixed point is wrapped with 2 turns, and the knot is fixed.

[0029] 7. Wound treatment: Check the reduction effect (the apple muscle is lifted by 5 mm, the tear groove is satisfactorily filled, and the eye bag disappears), cut off the excess suture, and apply erythromycin ointment to the puncture point. Pressurized dressing for 8 minutes.

[0030] 8. Postoperative care: Tell the patient to apply cold compress within 48 hours after the operation (15 minutes each time, 3 times a day), avoid strenuous exercise, and do not need to remove the stitches. Review after 7 days, and prohibit eye massage within 1 month.

[0031] The operation time of this embodiment is 9 minutes. The apple muscle is reset immediately after the operation, and the tear groove, eye bag, and Indian lines are significantly improved without obvious swelling and bleeding. The puncture point heals without scar after 7 days. Follow-up after 6 months shows that the reduction effect is stable, and there are no complications such as fat displacement and nerve injury.

[0032] The above is only a specific embodiment of the present application, which enables those skilled in the art to understand or implement the present application. Various modifications to these embodiments will be apparent to those skilled in the art, and the general principles defined in the present application can be implemented in other embodiments without departing from the spirit or scope of the present application. Therefore, the present application will not be limited to these embodiments shown in the present application, but will conform to the widest scope consistent with the principles and novel features of the present application.

Claims

1. A novel conjunctivochalasis apple muscle repositioning method, characterized by, The method comprises the following steps: S1, preoperative positioning; The preoperative positioning comprises marking two puncture points on the medial and lateral sides of the lower eyelid conjunctival fornix, determining the orbital septum fat bulging area, SOOF lifting target point and lower migration range of the malar fat pad; S2, minimally invasive puncture; The minimally invasive puncture uses a 21G blunt needle to puncture the subconjunctival tissue from the two puncture points, separates along the superficial layer of the orbital septum to the preset operation area, and the separation range is controlled within 1.5-2.0 cm² to avoid damaging the palpebral arterial arch and infraorbital nerve; S3, orbital septum tightening and fixation; The orbital septum tightening and fixation uses a 5-0 non-absorbable polyethylene terephthalate suture, and 3-4 needles of continuous suture are performed between the attachment point of the lateral wall of the orbital septum and the central part of the orbital septum by the needle embedding suture technique, so that the orbital septum and the orbital septum fat are moved downward by 3-5 mm and tightened, and the suture tension is controlled within 0.3-0.5 N; S4, SOOF lifting and anchoring; The SOOF lifting and anchoring passes the free end of the suture through the SOOF layer in the front 1 / 3 area of the malar arch, performs 1-2 horizontal mattress sutures, lifts the SOOF layer to move upward by 4-6 mm, and the knot tying strength is determined by the standard of no sliding of the SOOF layer, and the knot is buried in the tissue after tying; S5, fat pad netting and ligation; The fat pad netting and ligation uses another suture to perform netting and cross suture through the same puncture channel, and the eye bag fat and the lower migration malar fat pad are fixed by ligation, and the suture grid aperture is 0.8-1.2 cm to ensure that the fat pad does not shift; S6, wound treatment; The wound treatment comprises removing the excess suture after confirming the reduction effect, not suturing the puncture point, applying an antibacterial ointment, and then applying pressure for 5-10 minutes.

2. A novel conjunctival incision apple muscle repositioning method according to claim 1, characterized in that: The breaking strength of the 5-0 non-absorbable polyethylene terephthalate suture is greater than or equal to 5.0 N, the wire diameter is 0.15-0.18 mm, the surface is treated with a polytetrafluoroethylene coating, and the friction coefficient is less than or equal to 0.

12.

3. A novel conjunctival incision apple muscle repositioning method according to claim 1, characterized in that: In the minimally invasive puncture, the distance between the puncture points is 2.5-3.5 cm, the puncture depth is controlled within 2.0-3.0 mm, physiological saline is continuously flushed and cooled during the separation process, and the temperature is maintained at 32-35°C.

4. A novel conjunctival incision apple muscle repositioning method according to claim 1, characterized in that: In the needle embedding suture technique, the needle distance of the orbital septum suture is 4-6 mm, the angle between the suture and the orbital septum tissue is 30-45°, and the orbital septum tension is uniformly distributed after suture to avoid local wrinkles.

5. A novel conjunctival incision apple muscle repositioning method according to claim 1, characterized in that: The SOOF lifting and anchoring position is 2.0-2.5 cm away from the infraorbital margin, and the suture depth is 1.5-2.0 mm to avoid penetrating the malar bone periosteum.

6. A novel conjunctival incision apple muscle repositioning method according to claim 1, characterized in that: The suture cross angle of the netting and ligation is 60-90°, the number of suture winding turns at each fat pad fixation point is 2-3 turns, the knot tying method adopts a surgical square knot to ensure the fixation stability, and there is no risk of fat shifting within 12 months after the operation.